Maravai Lifesciences Holdings, Inc. Class A MRVI
NASDAQ · United States · Health Technology
$7.56-0.10 (-1.31%)
Market open· · USD · Data may be delayed
Prices may be delayed and are for informational purposes only - not investment advice.
Market open· · USD · Data may be delayed
Prices may be delayed and are for informational purposes only - not investment advice.
| Quarter | Report date | Actual EPS | Estimated EPS | EPS surprise | Actual revenue | Revenue surprise | Price reaction |
|---|---|---|---|---|---|---|---|
| Q2 2026 | 2026-08-06 | -0.02 | -0.04 | +54.1% | $51.44M | +5.7% | -2.8%$6.41→$6.23 |
| Q1 2026 | 2026-05-07 | -0.03 | -0.07 | +57.1% | — | — | +23.1% |
| Q4 2025 | 2026-02-25 | -0.07 | -0.09 | +22.2% | — | — | +14.1%$3.12→$3.56 |
| Q3 2025 | 2025-11-06 | -0.14 | -0.08 | -75.0% | — | — | 0.0%$2.87→$2.87 |
| Q2 2025 | 2025-08-11 | -0.08 | -0.07 | -14.3% | — | — | — |
| Q4 2024 | 2025-03-18 | -0.06 | -0.04 | -50.0% | — | — | — |
The price reaction is the change from the last close before the announcement date to the first close after it - the report may land before the open, during the session or after the close, so this window covers all three. Not investment advice.